Because IGFBP2 has been shown to modulate both the IGF and integrin pathways and is a mediator of cell growth, invasion, and resistance in other tumor types [22–37, 39, 40], we evaluated the functional role of IGFBP2 in EAC progression and chemoresistance. The gene discussed is IGFBP2; the disease is neoplasm.